Global Chemotherapy-induced Nausea and Vomiting Drugs Market Research Report 2021

Publisher Name :
Date: 22-Jan-2021
No. of pages: 91
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Existing Drugs

- Akynzeo (Netupitant-Palonosetron FDC)

- Aloxi (Palonosetron)

- Emend (Aprepitant)

- Kytril Generic (Granisetron)

- Zofran Generic (Ondansetron)

- Pipeline Drugs

- SUSTOL (Granisetron Injection extended release)

- Rolapitant

Segment by Application

- Serotonin Receptor Antagonists

- NK1 Receptor Antagonists

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Merck & Co., Inc.

- GlaxoSmithKline plc

- Tesaro, Inc.

- Helsinn Group

- F. Hoffmann-La Roche Ltd.

- Heron Therapeutics, Inc.

- Dr. Reddy's Laboratories Ltd.

- Acacia Pharma

- Sun Pharmaceutical Industry Ltd.

- Otsuka Holdings Co., Ltd.

Global Chemotherapy-induced Nausea and Vomiting Drugs Market Research Report 2021

Table of Contents
1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview
1.1 Product Overview and Scope of Chemotherapy-Induced Nausea and Vomiting Drugs
1.2 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Type
1.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Existing Drugs
1.2.3 Akynzeo (Netupitant-Palonosetron FDC)
1.2.4 Aloxi (Palonosetron)
1.2.5 Emend (Aprepitant)
1.2.6 Kytril Generic (Granisetron)
1.2.7 Zofran Generic (Ondansetron)
1.2.8 Pipeline Drugs
1.2.9 SUSTOL (Granisetron Injection extended release)
1.2.10 Rolapitant
1.3 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Application
1.3.1 Chemotherapy-Induced Nausea and Vomiting Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Serotonin Receptor Antagonists
1.3.3 NK1 Receptor Antagonists
1.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Estimates and Forecasts
1.4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue 2016-2027
1.4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales 2016-2027
1.4.3 Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region: 2016 Versus 2021 Versus 2027
2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Competition by Manufacturers
2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Sites, Area Served, Product Type
2.5 Chemotherapy-Induced Nausea and Vomiting Drugs Market Competitive Situation and Trends
2.5.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Chemotherapy-Induced Nausea and Vomiting Drugs Players Market Share by Revenue
2.5.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chemotherapy-Induced Nausea and Vomiting Drugs Retrospective Market Scenario by Region
3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.3.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country
3.3.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.4.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country
3.4.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region
3.5.2 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.6.1 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country
3.6.2 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country
3.7.2 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historic Market Analysis by Type
4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2021)
4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2016-2021)
5 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historic Market Analysis by Application
5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2021)
5.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Merck & Co., Inc.
6.1.1 Merck & Co., Inc. Corporation Information
6.1.2 Merck & Co., Inc. Description and Business Overview
6.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck & Co., Inc. Product Portfolio
6.1.5 Merck & Co., Inc. Recent Developments/Updates
6.2 GlaxoSmithKline plc
6.2.1 GlaxoSmithKline plc Corporation Information
6.2.2 GlaxoSmithKline plc Description and Business Overview
6.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GlaxoSmithKline plc Product Portfolio
6.2.5 GlaxoSmithKline plc Recent Developments/Updates
6.3 Tesaro, Inc.
6.3.1 Tesaro, Inc. Corporation Information
6.3.2 Tesaro, Inc. Description and Business Overview
6.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Tesaro, Inc. Product Portfolio
6.3.5 Tesaro, Inc. Recent Developments/Updates
6.4 Helsinn Group
6.4.1 Helsinn Group Corporation Information
6.4.2 Helsinn Group Description and Business Overview
6.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Helsinn Group Product Portfolio
6.4.5 Helsinn Group Recent Developments/Updates
6.5 F. Hoffmann-La Roche Ltd.
6.5.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.5.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 F. Hoffmann-La Roche Ltd. Product Portfolio
6.5.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.6 Heron Therapeutics, Inc.
6.6.1 Heron Therapeutics, Inc. Corporation Information
6.6.2 Heron Therapeutics, Inc. Description and Business Overview
6.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Heron Therapeutics, Inc. Product Portfolio
6.6.5 Heron Therapeutics, Inc. Recent Developments/Updates
6.7 Dr. Reddy's Laboratories Ltd.
6.6.1 Dr. Reddy's Laboratories Ltd. Corporation Information
6.6.2 Dr. Reddy's Laboratories Ltd. Description and Business Overview
6.6.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Dr. Reddy's Laboratories Ltd. Product Portfolio
6.7.5 Dr. Reddy's Laboratories Ltd. Recent Developments/Updates
6.8 Acacia Pharma
6.8.1 Acacia Pharma Corporation Information
6.8.2 Acacia Pharma Description and Business Overview
6.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Acacia Pharma Product Portfolio
6.8.5 Acacia Pharma Recent Developments/Updates
6.9 Sun Pharmaceutical Industry Ltd.
6.9.1 Sun Pharmaceutical Industry Ltd. Corporation Information
6.9.2 Sun Pharmaceutical Industry Ltd. Description and Business Overview
6.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Sun Pharmaceutical Industry Ltd. Product Portfolio
6.9.5 Sun Pharmaceutical Industry Ltd. Recent Developments/Updates
6.10 Otsuka Holdings Co., Ltd.
6.10.1 Otsuka Holdings Co., Ltd. Corporation Information
6.10.2 Otsuka Holdings Co., Ltd. Description and Business Overview
6.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Otsuka Holdings Co., Ltd. Product Portfolio
6.10.5 Otsuka Holdings Co., Ltd. Recent Developments/Updates
7 Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Cost Analysis
7.1 Chemotherapy-Induced Nausea and Vomiting Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs
7.4 Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors List
8.3 Chemotherapy-Induced Nausea and Vomiting Drugs Customers
9 Chemotherapy-Induced Nausea and Vomiting Drugs Market Dynamics
9.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Trends
9.2 Chemotherapy-Induced Nausea and Vomiting Drugs Growth Drivers
9.3 Chemotherapy-Induced Nausea and Vomiting Drugs Market Challenges
9.4 Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints
10 Global Market Forecast
10.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Chemotherapy-Induced Nausea and Vomiting Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Chemotherapy-Induced Nausea and Vomiting Drugs by Type (2022-2027)
10.2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Chemotherapy-Induced Nausea and Vomiting Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Chemotherapy-Induced Nausea and Vomiting Drugs by Application (2022-2027)
10.3 Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Chemotherapy-Induced Nausea and Vomiting Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Chemotherapy-Induced Nausea and Vomiting Drugs by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Covered in This Study
Table 5. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Chemotherapy-Induced Nausea and Vomiting Drugs Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Type
Table 12. Global Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Chemotherapy-Induced Nausea and Vomiting Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Type (2016-2021)
Table 39. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Type (2016-2021)
Table 42. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Type (2016-2021)
Table 43. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Application (2016-2021)
Table 44. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Application (2016-2021)
Table 47. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Application (2016-2021)
Table 48. Merck & Co., Inc. Corporation Information
Table 49. Merck & Co., Inc. Description and Business Overview
Table 50. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 52. Merck & Co., Inc. Recent Developments/Updates
Table 53. GlaxoSmithKline plc Corporation Information
Table 54. GlaxoSmithKline plc Description and Business Overview
Table 55. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 57. GlaxoSmithKline plc Recent Developments/Updates
Table 58. Tesaro, Inc. Corporation Information
Table 59. Tesaro, Inc. Description and Business Overview
Table 60. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 62. Tesaro, Inc. Recent Developments/Updates
Table 63. Helsinn Group Corporation Information
Table 64. Helsinn Group Description and Business Overview
Table 65. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 67. Helsinn Group Recent Developments/Updates
Table 68. F. Hoffmann-La Roche Ltd. Corporation Information
Table 69. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 70. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 72. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 73. Heron Therapeutics, Inc. Corporation Information
Table 74. Heron Therapeutics, Inc. Description and Business Overview
Table 75. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 77. Heron Therapeutics, Inc. Recent Developments/Updates
Table 78. Dr. Reddy's Laboratories Ltd. Corporation Information
Table 79. Dr. Reddy's Laboratories Ltd. Description and Business Overview
Table 80. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 82. Dr. Reddy's Laboratories Ltd. Recent Developments/Updates
Table 83. Acacia Pharma Corporation Information
Table 84. Acacia Pharma Description and Business Overview
Table 85. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 87. Acacia Pharma Recent Developments/Updates
Table 88. Sun Pharmaceutical Industry Ltd. Corporation Information
Table 89. Sun Pharmaceutical Industry Ltd. Description and Business Overview
Table 90. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 92. Sun Pharmaceutical Industry Ltd. Recent Developments/Updates
Table 93. Otsuka Holdings Co., Ltd. Corporation Information
Table 94. Otsuka Holdings Co., Ltd. Description and Business Overview
Table 95. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 97. Otsuka Holdings Co., Ltd. Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Chemotherapy-Induced Nausea and Vomiting Drugs Distributors List
Table 101. Chemotherapy-Induced Nausea and Vomiting Drugs Customers List
Table 102. Chemotherapy-Induced Nausea and Vomiting Drugs Market Trends
Table 103. Chemotherapy-Induced Nausea and Vomiting Drugs Growth Drivers
Table 104. Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints
Table 105. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 106. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 110. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 114. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure 2. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Type in 2020 & 2027
Figure 3. Existing Drugs Product Picture
Figure 4. Akynzeo (Netupitant-Palonosetron FDC) Product Picture
Figure 5. Aloxi (Palonosetron) Product Picture
Figure 6. Emend (Aprepitant) Product Picture
Figure 7. Kytril Generic (Granisetron) Product Picture
Figure 8. Zofran Generic (Ondansetron) Product Picture
Figure 9. Pipeline Drugs Product Picture
Figure 10. SUSTOL (Granisetron Injection extended release) Product Picture
Figure 11. Rolapitant Product Picture
Figure 12. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Application in 2020 & 2027
Figure 13. Serotonin Receptor Antagonists
Figure 14. NK1 Receptor Antagonists
Figure 15. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2016-2027 (US$ Million)
Figure 17. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales 2016-2027 (K Units)
Figure 18. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 19. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Manufacturers in 2020
Figure 20. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Manufacturers in 2020
Figure 21. The Global 5 and 10 Largest Chemotherapy-Induced Nausea and Vomiting Drugs Players: Market Share by Revenue in 2020
Figure 22. Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 23. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region (2016-2021)
Figure 24. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region in 2020
Figure 25. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region (2016-2021)
Figure 26. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region in 2020
Figure 27. U.S. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Canada Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Germany Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. France Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. U.K. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Italy Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Russia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. South Korea Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Australia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Taiwan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Indonesia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Thailand Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Malaysia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Philippines Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Vietnam Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Mexico Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Brazil Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Argentina Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Turkey Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. U.A.E Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Sales Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Type (2016-2021)
Figure 52. Sales Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Application (2016-2021)
Figure 53. Sales Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Application in 2020
Figure 54. Revenue Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Application (2016-2021)
Figure 55. Revenue Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Application in 2020
Figure 56. Manufacturing Cost Structure of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure 57. Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure 58. Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
  • Global Polyene Phosphatidylcholine Market Research Report 2021
    Published: 08-Mar-2021        Price: US 2900 Onwards        Pages: 98
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Capsule - Injection Segment by Application - Hospital - Clinic - Other ......
  • Global Haarlem Oil Market Research Report 2021
    Published: 08-Mar-2021        Price: US 2900 Onwards        Pages: 92
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Pharmaceuticals - Dietary Supplements Segment by Application - Horse - Other ......
  • Global Gleptoferron (Iron-Dextran Heptonic Acid Complex) Market Research Report 2021
    Published: 08-Mar-2021        Price: US 2900 Onwards        Pages: 96
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Oral Type - Injection Type Segment by Application - Poultry - Porcine - Livest......
  • Global Disinfectants For Haemodialysis Market Research Report 2021
    Published: 08-Mar-2021        Price: US 2900 Onwards        Pages: 91
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Chlorine-Based Disinfectants - Acetic Acid-Based Disinfectants - Other Segment by Applicatio......
  • Global Squalane Oil Market Research Report 2021
    Published: 08-Mar-2021        Price: US 2900 Onwards        Pages: 124
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Phyto Squalane - Shark Squalane - Synthetic Squalane Segment by Application - Cosmeti......
  • Global Hash Oil Market Research Report 2021
    Published: 08-Mar-2021        Price: US 2900 Onwards        Pages: 97
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Organic Type - Non-Organic Type Segment by Application - Recreational - Medical......
  • Global Cytokinins Market Research Report 2021
    Published: 08-Mar-2021        Price: US 2900 Onwards        Pages: 97
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Adenine-type - Phenylurea-type Segment by Application - Agriculture - Healthcare......
  • Global Prenatal Vitamins Market Research Report 2021
    Published: 08-Mar-2021        Price: US 2900 Onwards        Pages: 121
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tablets - Capsules Segment by Application - Drug store - Online Pharmacies - S......
  • Global Prenatal Vitamin Preparation Market Research Report 2021
    Published: 08-Mar-2021        Price: US 2900 Onwards        Pages: 97
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tablets - Capsules Segment by Application - Drug store - Online Pharmacies - S......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs